Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1902802

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1902802

Blood Glucose Test Strips Market Size, Share, and Growth Analysis, By Application (Type 1, Type 2), By End Use (Individuals, Hospitals And Clinics), By Technology, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Blood Glucose Test Strips Market size was valued at USD 2.35 Billion in 2024 and is poised to grow from USD 2.57 Billion in 2025 to USD 5.28 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).

The blood glucose test strips market is a crucial segment in the healthcare sector, essential for effective diabetes management. With the increasing prevalence of diabetes globally, the demand for these test strips continues to grow. A significant rise in the adult population affected by diabetes underscores the necessity for regular blood glucose monitoring. Recent trends indicate a shift towards advanced monitoring technologies, such as continuous glucose monitoring (CGM) systems, which provide real-time data and minimize the reliance on traditional test strips. However, despite the emerging popularity of CGM devices, blood glucose test strips maintain their status as the favored option for self-monitoring due to their affordability and ease of use, ensuring they remain integral to diabetes care strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Blood Glucose Test Strips market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Blood Glucose Test Strips Market Segments Analysis

Global Blood Glucose Test Strips Market is segmented by Application, End Use, Technology And Region. Based on Application, the market is segmented into diabetes. Based on End Use, the market is segmented into individuals, hospitals and clinics and others. Based on Technology, the market is segmented into glucose dehydrogenase (GDH), glucose oxidase and others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Blood Glucose Test Strips Market

The blood glucose test strips market is experiencing notable growth driven by heightened awareness of diabetes management and rising healthcare investment. As more individuals recognize the importance of managing diabetes, there is a corresponding increase in the adoption of glucose monitoring devices. Additionally, healthcare organizations and governments around the globe are prioritizing the early detection and efficient management of diabetes. This focus has resulted in improved access to and utilization of blood glucose test strips, contributing to the overall expansion of this market as more people seek proactive measures to maintain their health and well-being.

Restraints in the Blood Glucose Test Strips Market

The blood glucose test strips market faces significant challenges due to the emergence of alternative glucose monitoring technologies, especially continuous glucose monitoring (CGM) systems. These advanced systems provide instant glucose readings while eliminating the need for regular fingerstick tests, thereby offering users a more convenient and user-friendly approach to monitoring their glucose levels. As consumers increasingly gravitate towards these innovative solutions, the demand for traditional blood glucose test strips may diminish. This shift highlights the growing preference for comprehensive glucose management options, which could adversely impact the market for conventional test strips in the long run.

Market Trends of the Blood Glucose Test Strips Market

The blood glucose test strips market is witnessing a notable trend towards the growing demand for efficient and convenient glucose monitoring solutions, particularly driven by the rise of continuous glucose monitoring (CGM) systems. These advanced technologies leverage subcutaneous sensors to provide real-time glucose level tracking, significantly reducing the reliance on traditional fingerstick tests. As consumers increasingly prioritize user-friendly and accurate health management tools, CGM systems are emerging as a preferred choice due to their ability to facilitate continuous monitoring and enhance management of blood sugar levels. This shift not only streamlines the testing process but also promotes better health outcomes.

Product Code: SQMIG35A2630

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Blood Glucose Test Strips Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Type 1
  • Type 2
  • Gestational Diabetes
  • Pre-Diabetes

Global Blood Glucose Test Strips Market Size by End Use & CAGR (2026-2033)

  • Market Overview
  • Individuals
  • Hospitals And Clinics
  • Others

Global Blood Glucose Test Strips Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Glucose Dehydrogenase (GDH)
  • Glucose Oxidase
  • Others

Global Blood Glucose Test Strips Market Size & CAGR (2026-2033)

  • North America (Application, End Use, Technology)
    • USA
    • Canada
  • Europe (Application, End Use, Technology)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Application, End Use, Technology)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Application, End Use, Technology)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Application, End Use, Technology)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaSorin S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sekisui Medical Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ortho Clinical Diagnostics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beckman Coulter, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Myriad Genetics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alere Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LabCorp (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ARUP Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MSD (Merck & Co., Inc.) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!